Profile data is unavailable for this security.
About the company
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
- Revenue in USD (TTM)0.00
- Net income in USD-26.86m
- Incorporated2008
- Employees59.00
- LocationPolyPid Ltd18 Hasivim Street,P.O Box 7126PETAH TIKVA 4917002IsraelISR
- Websitehttps://www.polypid.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TherapeuticsMD Inc | 1.60m | -3.97m | 15.80m | 1.00 | -- | 0.5831 | -- | 9.90 | -0.3499 | -0.291 | 0.1399 | 2.35 | 0.0355 | -- | 0.4944 | 1,596,000.00 | -8.81 | -53.35 | -11.41 | -111.61 | 31.45 | 86.67 | -248.56 | -236.57 | -- | -- | 0.00 | -- | -98.14 | -39.53 | -816.85 | -- | -- | -- |
| Cara Therapeutics Inc | 8.69m | -95.53m | 16.74m | 55.00 | -- | 23.67 | -- | 1.93 | -1.75 | -1.75 | 0.1589 | 0.0129 | 0.1042 | 0.6312 | 4.59 | 157,927.30 | -114.63 | -35.76 | -142.84 | -40.82 | 56.44 | -- | -1,099.76 | -162.10 | 4.71 | -- | 0.00 | -- | -49.92 | 9.26 | -38.65 | -- | 100.66 | -- |
| Gelteq Ltd | 0.00 | -1.54m | 17.27m | -- | -- | 1.22 | -- | -- | -0.1609 | -0.1609 | 0.00 | 1.50 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.38 | -32.41 | 0.0605 | -- | -- | -- | -72.77 | -- | -- | -- |
| Marinus Pharmaceuticals Inc | 31.47m | -140.49m | 17.90m | 165.00 | -- | -- | -- | 0.5689 | -2.47 | -2.47 | 0.5524 | -1.21 | 0.238 | 0.6542 | 7.75 | 190,703.00 | -106.26 | -49.64 | -140.93 | -57.76 | 90.17 | -- | -446.49 | -518.96 | 1.47 | -10.06 | -- | -- | 21.63 | -- | -613.59 | -- | 7.47 | -- |
| BioXcel Therapeutics Inc | 2.28m | -71.00m | 20.74m | 74.00 | -- | -- | -- | 9.11 | -2.15 | -2.15 | 0.0637 | -2.02 | 0.0305 | 1.14 | 6.17 | 30,756.76 | -95.08 | -74.57 | -168.28 | -84.06 | 10.98 | -- | -3,119.33 | -32,300.74 | 1.81 | -6.54 | 5.55 | -- | 268.00 | -- | -8.02 | -- | -43.26 | -- |
| Cyclo Therapeutics Inc | 870.72k | -24.80m | 20.95m | 8.00 | -- | -- | -- | 24.06 | -0.9232 | -0.9232 | 0.0322 | -0.4683 | 0.1605 | 0.342 | 3.54 | 108,840.00 | -457.10 | -132.22 | -- | -215.17 | 91.24 | 90.37 | -2,848.18 | -1,114.04 | 0.1614 | -- | -- | -- | -21.76 | 1.25 | -29.81 | -- | -3.95 | -- |
| China Health Industries Holdings, Inc. | 95.95k | -1.36m | 21.30m | 32.00 | -- | -- | -- | 221.99 | -0.0208 | -0.0208 | 0.0015 | -0.0366 | 0.0037 | 0.5035 | 20.57 | 2,998.44 | -5.18 | 3.04 | -6.89 | 3.66 | -5.34 | 69.55 | -1,419.49 | 28.61 | 0.0377 | -- | 1.76 | -- | 41,225.93 | -55.72 | -15.49 | -- | -- | -- |
| Nexgel Inc | 6.73m | -3.53m | 22.47m | 19.00 | -- | 4.81 | -- | 3.34 | -0.5815 | -0.5815 | 1.10 | 0.6902 | 0.6558 | 3.21 | 6.56 | 354,105.30 | -37.28 | -44.61 | -51.10 | -56.19 | 31.61 | 5.02 | -56.85 | -180.98 | 0.9291 | -- | 0.2235 | -- | 99.66 | 13.06 | 33.48 | -- | -- | -- |
| Polypid Ltd | 0.00 | -26.86m | 24.12m | 59.00 | -- | 11.18 | -- | -- | -7.48 | -7.48 | 0.00 | 0.3172 | 0.00 | -- | -- | 0.00 | -132.55 | -76.92 | -222.42 | -89.61 | -- | -- | -- | -- | -- | -25.48 | 0.7813 | -- | -- | -- | 39.67 | -- | -42.34 | -- |
| Natural Alternatives International, Inc. | 112.98m | -8.50m | 26.10m | 296.00 | -- | 0.3255 | -- | 0.231 | -1.45 | -1.45 | 19.19 | 12.94 | 0.7028 | 4.35 | 8.25 | 381,679.10 | -5.29 | 2.33 | -6.04 | 2.80 | 5.30 | 14.24 | -7.53 | 2.06 | 1.50 | -9.35 | 0.1536 | 0.00 | -26.11 | -3.82 | -386.16 | -- | -10.75 | -- |
| Dare Bioscience Inc | 1.88m | -3.60m | 29.04m | 23.00 | -- | -- | -- | 15.43 | -0.5276 | -0.5276 | 0.2303 | -0.1737 | 0.0873 | -- | 2.28 | 81,796.52 | -16.72 | -109.51 | -199.47 | -246.26 | 3.50 | -- | -191.61 | -1,104.55 | -- | -- | -- | -- | -71.92 | -- | 2.54 | -- | 121.37 | -- |
| KALA BIO Inc | 0.00 | -38.96m | 31.31m | 43.00 | -- | 4.57 | -- | -- | -12.47 | -12.47 | 0.00 | 1.49 | 0.00 | -- | -- | 0.00 | -67.64 | -57.83 | -96.17 | -69.32 | -- | 57.06 | -- | -1,553.61 | -- | -11.21 | 0.8367 | -- | -100.00 | -- | 5.85 | -- | -17.31 | -- |
| Opus Genetics Inc | 8.38m | -27.19m | 31.75m | 14.00 | -- | 0.7714 | -- | 3.79 | -1.09 | -1.09 | 0.3369 | 1.31 | 0.1772 | -- | 1.14 | 598,642.90 | -57.50 | -58.31 | -64.30 | -65.94 | -- | -- | -324.45 | -137.92 | -- | -- | 0.00 | -- | -52.20 | -- | -155.83 | -- | -- | -- |
| Akari Therapeutics PLC (ADR) | 0.00 | -20.13m | 32.19m | 9.00 | -- | -- | -- | -- | -2.98 | -2.98 | 0.00 | -0.3049 | 0.00 | -- | -- | 0.00 | -307.64 | -149.95 | -- | -435.18 | -- | -- | -- | -- | -- | -378.19 | -- | -- | -- | -- | 43.61 | -- | -- | -- |
| ImmuCell Corp | 23.84m | -3.81m | 32.88m | 74.00 | -- | 1.23 | -- | 1.38 | -0.4856 | -0.4856 | 3.03 | 2.99 | 0.5357 | 2.35 | 11.43 | 301,746.80 | -8.56 | -5.16 | -9.39 | -5.53 | 26.71 | 40.04 | -15.99 | -12.64 | 1.44 | -6.21 | 0.2922 | -- | -5.90 | 9.72 | -131.56 | -- | -1.39 | -- |
Data as of Nov 22 2024. Currency figures normalised to PolyPid Ltd's reporting currency: US Dollar USD
40.06%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| AIGH Capital Management LLCas of 30 Sep 2024 | 679.67k | 14.17% |
| Rosalind Advisors, Inc.as of 30 Sep 2024 | 679.17k | 14.16% |
| DAFNA Capital Management LLCas of 30 Sep 2024 | 308.50k | 6.43% |
| Stonepine Capital Management LLCas of 30 Sep 2024 | 138.50k | 2.89% |
| Adar1 Capital Management LLCas of 30 Sep 2024 | 93.90k | 1.96% |
| Yelin Lapidot Mutual Fund Management Ltd.as of 30 Sep 2024 | 11.15k | 0.23% |
| Steward Partners Investment Advisory LLCas of 30 Sep 2024 | 7.35k | 0.15% |
| UBS Securities LLCas of 30 Sep 2024 | 1.99k | 0.04% |
| TD Waterhouse Canada, Inc.as of 30 Sep 2024 | 781.00 | 0.02% |
| Morgan Stanley & Co. LLCas of 30 Sep 2024 | 632.00 | 0.01% |
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
